ARCHIVED - Monthly Issue

 

Canada Communicable Disease Report
CCDR ISSN 1481-8531 (On-line)

2007 - Volume 33


Volume 33-13, December 1, 2007

  • The process to establish and implement national goals and recommendations for vaccine preventable diseases in Canada under the national immunization strategy
  • Summary of the outcomes from the national consensus conference for vaccine-preventable diseases in Canada, Quebec, Quebec, june 12-14, 2005
  • Initial health screening results for Karen refugees: a retrospective review

Volume 33-12, November 1, 2007

  • The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination
  • A community outbreak of travel-acquired hepatitis A transmitted by an infected food handler
  • ADDENDUM - National Advisory Committee on Immunization (NACI) Statement on Influenza Vaccination for the 2007-2008 Season Vol. 33, ACS-7, 1 July 2007

Volume 33-11, October 1, 2007

  • A provincial and territorial review of hepatitis A in men who have sex with men
  • Descriptive epidemiology of Vibrio  parahaemolyticus and other Vibrio species infections in British Columbia: 2001-2006
  • Encephalitis in the summer: a case of snowshoe hare (California serogroup) virus infection in Nova Scotia
  • Notifiable Diseases Summary
  • Special report of the Canadian Tuberculosis Committee - Tuberculosis and HIV co-infection in Canada - ERRATUM

Volume 33-10, June 1, 2007

  • Enhanced Surveillance of Invasive Meningococcal Disease in Canada:
    1 January, 2004, through 31 December, 2005

Volume 33-09, May 1, 2007

  • Influenza in Canada: 2006-2007 Season Update

Volume 33-08, April 15, 2007

  • Special Report of the Canadian Tuberculosis Committee Tuberculosis and HIV co-infection in Canada

Volume 33-07, April 1, 2007

  • Descriptive epidemiology of verotoxin-producing E. coli reported in Ontario, 1996-2005

Volume 33-06, March 15, 2007

  • Case series descriptive analysis of a primary syphilis
    outbreak in Edmonton, Alberta, July 2004-April 2006

Volume 33-05, March 1, 2007

  • Risk behaviours for infection with HIV and hepatitis C virus among people who inject drugs in Regina, Saskatchewan

Volume 33-04, February 15, 2007

  • Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission
  • Possible transmission of hepatitis A in a school setting

Volume 33-03, February 1, 2007

  • Influenza in Canada: 2005-2006 season
  • Notifiable Diseases Summary

Volume 33-02, January 15, 2007

  • Rapid emergence of methicillin-resistant Staphylococcus aureus (MRSA) among children and adolescents in northern Manitoba, 2003-2006
  • Outbreak of Escherichia coli O157:H7 gastroenteritis associated
    with consumption of beef donairs, Edmonton, Alberta,
    May-June 2006

Volume 33-01, January 1, 2007

  • Overview of the immunization product quality control practices of vaccinators in Montérégie


Advisory Committee Statements and Supplements to the CCDR

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Meningococcal C conjugate vaccination recommendations for infants
ACS- 11 - November 2007

An Advisory Committee Statement (ACS)
Canadian Tuberculosis Committee
Interferon gamma release assays for latent tuberculosis infection
ACS- 10 - 1 November 2007

An Advisory Committee Statement (ACS)
Canadian Tuberculosis Committee
Housing conditions that serve as risk factors
for tuberculosis infection and disease

ACS- 9 - 1 October 2007

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on Mumps Vaccine
ACS- 8 - 1 August 2007

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on Influenza Vaccination for the 2007-2008 Season
ACS- 7 - 1 July 2007

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Thimerosal: Updated Statement
ACS- 6 - 1 July 2007

An Advisory Committee Statement (ACS)
Committee to Advise on Tropical Medicine and Travel (CATMAT)
Statement on high-altitude illnesses
ACS- 5 - 1 April 2007

An Advisory Committee Statement (ACS)
Committee to Advise on Tropical Medicine and Travel (CATMAT)
The Immunocompromised Traveller
ACS- 4 - 1 April 2007

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135
ACS -3 - 1 May 2007

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on human papillomavirus vaccine
ACS -2 - 15 February 2007

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on the recommended use of pentavalent and hexavalent vaccines
ACS -1 - 1 February 2007

Point-of-Care HIV Testing Using Rapid HIV Test Kits: Guidance for Health-Care Professionals
CCDR Volume 33S2, November 2007

2004 Canadian Sexually Transmitted Infections Surveillance Report
CCDR Volume 33S1, May 2007

Page details

Date modified: